Literature DB >> 19541333

[Paradoxical response during anti-tuberculosis treatment in immunocompetent patients].

Angel Fernández-Fúnez1.   

Abstract

The exacerbation of clinical symptoms or radiological worsening of pre-existing tuberculous lesions or the development of new lesions defines paradoxical deterioration during antituberculosis therapy. This phenomenon is relatively frequent: it is observed between 6 and 30% of patients receiving antituberculous therapy. The pathogenesis is not completely clear and it is generally regarded as an abnormal immune response to the proteins released from dead bacilli. Clinical and radiological manifestations may locate in the central nervous system, lungs, pleura, lymph nodes and skin. The diagnosis is frequently difficult and outcome is most often spontaneously favourable. It is possible that the addition of corticosteroid therapy could be beneficial on the outcome of this phenomenon. In this paper we try to review the definition, pathogenesis, clinical manifestations and treatment of this pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541333     DOI: 10.1016/j.medcli.2008.12.020

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  Paradoxical response to tuberculosis treatment producing bowel obstruction.

Authors:  Heriberto Medina-Franco; Adriana Simoneta Pimienta-Ibarra; Rita Dorantes-Heredia; Joaquin Nuñez-Gómez; Francisco Ulises Pastor-Sifuentes
Journal:  Int J Colorectal Dis       Date:  2015-02-27       Impact factor: 2.571

2.  Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort.

Authors:  S W Lee; S H Lee; J-J Yim
Journal:  Infection       Date:  2012-05-15       Impact factor: 3.553

3.  Tuberculosis-immune reconstitution inflammatory syndrome in HIV-negative children.

Authors:  Apinya Palamit; Prakarn Tovichien; Ramida Amornsitthiwat
Journal:  Respirol Case Rep       Date:  2022-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.